Objectives: Identify the incidence of haematological adverse effects associated with linezolid.
Methods: Medical records of 27 hospitalised patients in South Africa with drug-resistant tuberculosis (DR-TB) and prescribed linezolid therapy were retrospectively reviewed.
Key Findings: Approximately a quarter (n = 7) of patients experienced haematological adverse effects.